CellFiber

CellFiber Co., Ltd. is revolutionizing the field of cell culture with their innovative platform technology, CellFiber™. This technology enables higher yields and product quality while ensuring stability, predictability, reproducibility, and scalability for cell and gene therapy applications. The company's focus on lowering costs and development timelines positions it as a game-changer in the biotechnology industry. The unique CellFiber™ technology, which consists of hollow and permeable alginate hydrogel outer shells and a cell-rich core region, allows for high-density cell culture, cost reduction, and scalable culture methods for commercial manufacturing. CellFiber Co., Ltd. has been developing scale-up manufacturing processes for various cells and vectors, with potential applications in multiple therapeutic areas. In terms of investment, the company recently secured a significant ¥830.00M Venture Round investment on 09 November 2023, with participation from JAFCO Japan, Real Tech Holdings, Universal Materials Incubator, Fast Track Initiative, Inc., and Chiba Dojo. This substantial investment reflects the confidence of industry players in the potential of CellFiber Co., Ltd. and its disruptive technology. As the company continues to develop its GMP CellFiber™ Extruders and expand its partnerships with CMOs, CDMOs, therapeutic companies, and pharmaceutical companies, it is poised for significant growth and impact in the biotechnology sector.